Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature

Despite the demonstrated benefit from epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) based therapies, EGFR mutant lung adenocarcinoma will eventually acquire drug resistance. Transformation to small-cell lung cancer (SCLC) is considered to be a rare resistance mechanism of E...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shi-Yu, Zhao, Jing, Wang, Meng-Zhao, Huo, Zhen, Zhang, Jing, Zhong, Wei, Xu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753919/
https://www.ncbi.nlm.nih.gov/pubmed/26871823
http://dx.doi.org/10.1097/MD.0000000000002752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753919/
https://www.ncbi.nlm.nih.gov/pubmed/26871823
http://dx.doi.org/10.1097/MD.0000000000002752

Ejemplares similares